Comment on Umapathysivam et al. Euglycemic Ketoacidosis in Two Patients Without Diabetes After Introduction of Sodium–Glucose Cotransporter 2 Inhibitor for Heart Failure With Reduced Ejection Fraction. Diabetes Care 2024;47:140–143
Diabetes Care · 2024
DOI: 10.2337/dc24-0094 ↗Kurz gefasst
Fallbericht in der Zeitschrift Diabetes Care, 2024. Verfasst von Foussard Ninon und 8 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Endocrinology-Diabetology-Nutrition and Cardiology, CHU Bordeaux, Bordeaux, France. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Ketoacidosis, Heart Failure. Die Arbeit nennt 5 Literaturangaben.
Themen: Herzinsuffizienz, Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departments of Endocrinology-Diabetology-Nutrition and Cardiology, CHU Bordeaux, Bordeaux, France.
ORCID-Profile: Rigalleau Vincent
Zitieren
APA
Ninon, F., Alice, L., Marie-Amélie, B. M., Laurence, B., Kamel, M., Thierry, C., Sami, F., Yann, P., & Vincent, R. (2024). Comment on Umapathysivam et al. Euglycemic Ketoacidosis in Two Patients Without Diabetes After Introduction of Sodium–Glucose Cotransporter 2 Inhibitor for Heart Failure With Reduced Ejection Fraction. Diabetes Care 2024;47:140–143. Diabetes Care. https://doi.org/10.2337/dc24-0094
Vancouver
Ninon F, Alice L, Marie-Amélie BM, Laurence B, Kamel M, Thierry C, et al. Comment on Umapathysivam et al. Euglycemic Ketoacidosis in Two Patients Without Diabetes After Introduction of Sodium–Glucose Cotransporter 2 Inhibitor for Heart Failure With Reduced Ejection Fraction. Diabetes Care 2024;47:140–143. Diabetes Care. 2024. doi:10.2337/dc24-0094
BibTeX
@article{Ninon2024,
author = {Ninon, Foussard and Alice, Larroumet and Marie-Amélie, Barbet-Massin and Laurence, Blanco and Kamel, Mohammedi and Thierry, Couffinhal and Sami, Fawaz and Yann, Pucheu and Vincent, Rigalleau},
title = {Comment on Umapathysivam et al. Euglycemic Ketoacidosis in Two Patients Without Diabetes After Introduction of Sodium–Glucose Cotransporter 2 Inhibitor for Heart Failure With Reduced Ejection Fraction. Diabetes Care 2024;47:140–143},
journal = {Diabetes Care},
year = {2024},
doi = {10.2337/dc24-0094}
}
EUVIMED